FDA panel backs shingles vaccine for the elderly: the pivotal study was in patients aged 60 and older, but approval for the 50-59 age group is also sought.(News): An article from: Family Practice News Books In Print, Audio Books.
FDA panel backs shingles vaccine for the elderly: the pivotal study was in patients aged 60 and older, but approval for the 50-59 age group is also sought.(News): An article from: Family Practice News buy bestselling books in print, audio books